24.09.2018Lonza investit 400 millions de CHF à Viège (VS)You are hereNewsLonza investit 400 millions de CHF à Viège (VS)
Find an actor
BioAlps World Visibitlity Package 201918.03.2019A yearly international programme for our affiliated companies to increase their visibility.
"Bristol-Myers Squibb to Acquire Celgene for About Billion""The combined company will have nine products with more than billion in annual sales"
Elanix Biotechnologies SATherapeutics & Diagnostics, Cell Therapy / Stem CellsElanix Biotechnologies SA develops and commercializes tissue regeneration products for acute and chronic wound care, and advanced skin care products for dermatological and gynaecological applications.
Additionally, Elanix provides services in cell therapy and related technologies.